My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Horizon Therapeutics Public Limited Company - Ordinary Shares (NQ:HZNP)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Horizon Therapeutics Public Limited Company - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Horizon Earnings Miss, Revenue Tops ↗

May 05, 2021

Horizon Therapeutics earnings fell short of Q1 estimates though revenue beat views. The biotech raised its 2021 revenue target.

Via Investor's Business Daily

Topics Earnings

Recap: Horizon Therapeutics Q1 Earnings ↗

May 05, 2021

Shares of Horizon Therapeutics (NASDAQ:HZNP) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share were down 92.50% year over year to $...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Biotech Cel-Sci Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗

April 28, 2021

Cel-Sci shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Biotech Applied Molecular Transport Stock Earns Relative Strength Rating Upgrade ↗

April 27, 2021

On Tuesday, Applied Molecular Transport stock reached an important technical milestone, seeing its Relative Strength Rating jump to 91 from 87.

Via Investor's Business Daily

3 Reasons to Buy Horizon Therapeutics Stock and 1 Not To ↗

April 17, 2021

Horizon Therapeutics's shares are up almost 200% over the past 12 months, buoyed by mind-boggling sales of its new blockbuster drug.

Via The Motley Fool

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

Does 2021's Best Biopharma to Work for Belong in Your Portfolio? ↗

April 07, 2021

Horizon Therapeutics has a clear path to significant sales growth.

Via The Motley Fool

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.